Ding Q, Hu W, Wang R, Yang Q, Zhu M, Li M, et al. Signaling pathways in rheumatoid arthritis: implications for targeted therapy. Sig Transduct Target Ther. 2023;8:68.
Gravallese EM, Firestein GS. Rheumatoid arthritis — common origins, divergent mechanisms. N Engl J Med. 2023;388:529–42.
Article CAS PubMed Google Scholar
Lönnblom E, Leu Agelii M, Sareila O, Cheng L, Xu B, Viljanen J, et al. Autoantibodies to disease-related proteins in joints as novel biomarkers for the diagnosis of rheumatoid arthritis. Arthritis Rheumatol. 2023;75:1110–9.
Luo P, Gao F-Q, Sun W, Li J-Y, Wang C, Zhang Q-Y, et al. Activatable fluorescent probes for imaging and diagnosis of rheumatoid arthritis. Military Med Res. 2023;10:31.
Bennett JL, Pratt AG, Dodds R, Sayer AA, Isaacs JD. Rheumatoid sarcopenia: loss of skeletal muscle strength and mass in rheumatoid arthritis. Nat Rev Rheumatol. 2023;19:239–51.
Article CAS PubMed Google Scholar
Peng X, Wang Q, Li W, Ge G, Peng J, Xu Y, et al. Comprehensive overview of microRNA function in rheumatoid arthritis. Bone Res. 2023;11:8.
Article CAS PubMed PubMed Central Google Scholar
Nikiphorou E, Philippou E. Nutrition and its role in prevention and management of rheumatoid arthritis. Autoimmun Rev. 2023;22:103333.
Article CAS PubMed Google Scholar
Han Y, Huang S. Nanomedicine is more than a supporting role in rheumatoid arthritis therapy. J Control Release. 2023;356:142–61.
Article CAS PubMed Google Scholar
Radu A-F, Bungau SG. Nanomedical approaches in the realm of rheumatoid arthritis. Ageing Res Rev. 2023;87: 101927.
Article CAS PubMed Google Scholar
Yang Y, Guo L, Wang Z, Liu P, Liu X, Ding J, et al. Targeted silver nanoparticles for rheumatoid arthritis therapy via macrophage apoptosis and re-polarization. Biomaterials. 2021;264:120390.
Article CAS PubMed Google Scholar
Lin G, Zhang M. Ligand chemistry in antitumor theranostic nanoparticles. Acc Chem Res. 2023;56:1578–90.
Article CAS PubMed PubMed Central Google Scholar
Lazzarotto Rebelatto ER, Rauber GS, Caon T. An update of nano-based drug delivery systems for cannabinoids: biopharmaceutical aspects & therapeutic applications. Int J Pharm. 2023;635:122727.
Article CAS PubMed Google Scholar
Vallorz EL, Janda J, Mansour HM, Schnellmann RG. Kidney targeting of formoterol containing polymeric nanoparticles improves recovery from ischemia reperfusion-induced acute kidney injury in mice. Kidney Int. 2022;102:1073–89.
Article CAS PubMed Google Scholar
Haque M, Shakil MS, Mahmud KM. The promise of nanoparticles-based radiotherapy in cancer treatment. Cancers. 2023;15:1892.
Article CAS PubMed PubMed Central Google Scholar
Li Y-S, Wu H-H, Jiang X-C, Zhang T-Y, Zhou Y, Huang L-L, et al. Active stealth and self-positioning biomimetic vehicles achieved effective antitumor therapy. J Control Release. 2021;335:515–26.
Article CAS PubMed Google Scholar
Wu H, Zhang T, Li N, Gao J. Cell membrane-based biomimetic vehicles for effective central nervous system target delivery: insights and challenges. J Control Release. 2023;360:169–84.
Article CAS PubMed Google Scholar
Zheng X, Zhang T, Huang T, Zhou Y, Gao J. Cell-derived membrane biomimetic nanocarriers for targeted therapy of pulmonary disease. Int J Pharm. 2022;620:121757.
Article CAS PubMed PubMed Central Google Scholar
Firestein GS, McInnes IB. Immunopathogenesis of rheumatoid arthritis. Immunity. 2017;46:183–96.
Article CAS PubMed PubMed Central Google Scholar
Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. The Lancet. 2016;388:2023–38.
Shipman JG, Onyenwoke RU, Sivaraman V. Calcium-dependent pulmonary inflammation and pharmacological interventions and mediators. Biology. 2021;10:1053.
Article CAS PubMed PubMed Central Google Scholar
Arita K, Hashimoto H, Shimizu T, Nakashima K, Yamada M, Sato M. Structural basis for Ca2+-induced activation of human PAD4. Nat Struct Mol Biol. 2004;11:777–83.
Article CAS PubMed Google Scholar
McInnes IB. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365:2205–19.
Article CAS PubMed Google Scholar
Rezaei Kahmini F, Shahgaldi S, Azimi M, Mansourabadi AH. Emerging therapeutic potential of regulatory T (Treg) cells for rheumatoid arthritis: new insights and challenges. Int Immunopharmacol. 2022;108:108858.
Article CAS PubMed Google Scholar
Belton CM, Goodwin PC, Fatherazi S, Schubert MM, Lamont RJ, Izutsu KT. Calcium oscillations in gingival epithelial cells infected with porphyromonas gingivalis. Microbes Infect. 2004;6:440–7.
Article CAS PubMed Google Scholar
Mydel P, Wang Z, Brisslert M, Hellvard A, Dahlberg LE, Hazen SL, et al. Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritis. J Immuno. 2010;184:6882–90.
Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immun Rev. 2010;233:233–55.
Article CAS PubMed Google Scholar
Ouboussad L, Burska AN, Melville A, Buch MH. Synovial tissue heterogeneity in rheumatoid arthritis and changes with biologic and targeted synthetic therapies to inform stratified therapy. Front Med. 2019;6:45.
Bromley M, Woolley DE. Histopathology of the rheumatoid lesion. Arthritis Rheum. 1984;27:857–63.
Article CAS PubMed Google Scholar
Onishi RM, Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology. 2010;129:311–21.
Article CAS PubMed PubMed Central Google Scholar
Schramm M, Leipe J, Schulze-Koops H, Skapenko A. Elevated expression of the Th17 cytokine interleukin 22 in rheumatoid arthritis. Ann Rheum Dis. 2010;69:A65–6.
Kotschenreuther K, Yan S, Kofler DM. Migration and homeostasis of regulatory T cells in rheumatoid arthritis. Front Immunol. 2022;13:947636.
Article CAS PubMed PubMed Central Google Scholar
Gao Y, Cai W, Zhou Y, Li Y, Cheng J, Wei F. Immunosenescence of T cells: a key player in rheumatoid arthritis. Inflamm Res. 2022;71:1449–62.
Comments (0)